KKR Acquires Majority Stake in HealthCare Royalty Partners

KKR & Co. Inc. (NYSE:KKR) is one of the 11 Best Revenue Growth Stocks to Buy Now. On July 30, KKR & Co. Inc. (NYSE:KKR) announced that it has completed its acquisition of a majority ownership stake in HealthCare Royalty Partners (HCRx), which is a middle-market biopharma royalty acquisition company.

This deal will help KKR & Co. Inc. (NYSE:KKR) enhance its capabilities in biopharma royalty and credit investing. It will also add about $3 billion to the company’s assets under management.

KKR Acquires Majority Stake in HealthCare Royalty Partners

A modern looking financial adviser sitting in front of a trading monitor, gesturing to a group of investors.

HCRx’s team and KKR’s health care team will work together closely to offer a range of financing solutions across the biopharma sector.

KKR & Co. Inc. (NYSE:KKR) has a long history of supporting health care companies around the world. Since 2004, the company has invested over $20 billion of equity capital in the sector.

KKR & Co. Inc. (NYSE:KKR) is a global investment firm focused on alternative asset management, capital markets, and insurance solutions.

READ NEXT: 12 Best Performing AI Stocks So Far in 2025 and 14 Best Aggressive Growth Stocks to Buy According to Analysts.

Disclosure: None. This article is originally published at Insider Monkey.